Interest in orodispersible films (ODF) is growing day-by-day, since this dosage form overcomes some therapeutic obstacles, such as impaired swallowing, and offers several benefits, such as the possibility to adapt the dosing requirements for a subset of patients. As a consequence, technologies to produce ODF have risen attention for possible applications in the development of patient-centric formulations. This review critically discusses current trends in the technology platforms proposed to manufacture ODF, including the innovation and opportunities to produce very small batches in a pharmacy setting. Although the main Pharmacopoeias recommend testing customized dosage forms for quality assurance, pharmaceutical assays are a matter of debate due to the complexity and high cost of conventional methods. Alternatively, non-disruptive online analytic methods can be proposed to assay ODF properties, above all to assure the uniformity of drug content.

Trends in the production methods of orodispersible films / U.M. Musazzi, G.M. Khalid, F. Selmin, P. Minghetti, F. Cilurzo. - In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. - ISSN 0378-5173. - 576(2020 Feb 25), pp. 118963.1-118963.10. [10.1016/j.ijpharm.2019.118963]

Trends in the production methods of orodispersible films

U.M. Musazzi;G.M. Khalid;F. Selmin;P. Minghetti;F. Cilurzo
2020

Abstract

Interest in orodispersible films (ODF) is growing day-by-day, since this dosage form overcomes some therapeutic obstacles, such as impaired swallowing, and offers several benefits, such as the possibility to adapt the dosing requirements for a subset of patients. As a consequence, technologies to produce ODF have risen attention for possible applications in the development of patient-centric formulations. This review critically discusses current trends in the technology platforms proposed to manufacture ODF, including the innovation and opportunities to produce very small batches in a pharmacy setting. Although the main Pharmacopoeias recommend testing customized dosage forms for quality assurance, pharmaceutical assays are a matter of debate due to the complexity and high cost of conventional methods. Alternatively, non-disruptive online analytic methods can be proposed to assay ODF properties, above all to assure the uniformity of drug content.
drug printing; flexographic printing; individualized medicine; orodispersible films; solvent casting
Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
25-feb-2020
16-dic-2019
Article (author)
File in questo prodotto:
File Dimensione Formato  
pre-proof.pdf

Open Access dal 26/02/2021

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 542.79 kB
Formato Adobe PDF
542.79 kB Adobe PDF Visualizza/Apri
1-s2.0-S0378517319310087-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 740.82 kB
Formato Adobe PDF
740.82 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/698879
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 67
  • ???jsp.display-item.citation.isi??? 62
social impact